Related Experiment Video
Updated: Feb 13, 2026

Isolation of Mouse Megakaryocyte Progenitors
Published on: May 20, 2021
Megakaryocyte ontogeny: Clinical and molecular significance
Kamaleldin E Elagib1, Ashton T Brock1, Adam N Goldfarb1
1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Abstract:
Fetal megakaryocytes (Mks) differ from adult Mks in key parameters that affect their capacity for platelet production. However, despite being smaller, more proliferative, and less polyploid, fetal Mks generally mature in the same manner as adult Mks. The phenotypic features unique to fetal Mks predispose patients to several disease conditions, including infantile thrombocytopenia, infantile megakaryoblastic leukemias, and poor platelet recovery after umbilical cord blood stem cell transplantations. Ontogenic Mk differences also affect new strategies being developed to address global shortages of platelet transfusion units. These donor-independent, ex vivo production platforms are hampered by the limited proliferative capacity of adult-type Mks and the inferior platelet production by fetal-type Mks. Understanding the molecular programs that distinguish fetal versus adult megakaryopoiesis will help in improving approaches to these clinical problems. This review summarizes the phenotypic differences between fetal and adult Mks, the disease states associated with fetal megakaryopoiesis, and recent advances in the understanding of mechanisms that determine ontogenic Mk transitions.
Insights
Fetal megakaryocytes (Mks) exhibit distinct traits impacting platelet production. Understanding these differences is crucial for treating infantile blood disorders and improving ex vivo platelet generation strategies.
Area of Science:
- Hematology
- Developmental Biology
- Cell Biology
Background:
- Fetal megakaryocytes (Mks) possess unique characteristics compared to adult Mks, influencing platelet production.
- These ontogenic differences contribute to specific disease conditions and challenges in ex vivo platelet production.
Purpose of the Study:
- To review phenotypic distinctions between fetal and adult Mks.
- To examine disease states linked to fetal megakaryopoiesis.
- To explore mechanisms driving developmental transitions in Mks.
Main Methods:
- Literature review of phenotypic, clinical, and molecular studies on fetal and adult megakaryopoiesis.
- Synthesis of current understanding of megakaryocyte ontogeny.
Main Results:
- Fetal Mks are smaller, more proliferative, and less polyploid than adult Mks, yet mature similarly.
- Unique fetal Mk features are associated with infantile thrombocytopenia, leukemias, and poor transplant outcomes.
- Challenges in ex vivo platelet production stem from limited adult Mk proliferation and inferior fetal Mk output.
Conclusions:
- Elucidating molecular programs differentiating fetal and adult Mks is key to advancing clinical strategies.
- Understanding ontogenic transitions can improve treatments for blood disorders and platelet transfusion shortages.
Related Concept Videos
Statistical Significance
Significance of Center of Mass
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Significance Testing: Overview
Significance of Displacement Current

